Recent IPO pricings and filings underscore sustained activity into late 2026, with Lycia Therapeutics raising $318 million at the top of its range on October 23 and OPay preparing a $320 million offering for late October. Multiple smaller biotech, industrial, and fintech deals have priced or filed in the prior 30 days, reflecting selective investor demand amid elevated Treasury yields and Nasdaq volatility. Larger candidates like Anthropic continue confidential preparations with potential marketing targeted before Thanksgiving, though OpenAI and several data-center names have deferred to 2027 amid valuation concerns and market conditions. This pipeline of confirmed late-year listings supports near-term resolution probabilities while highlighting execution risks for high-profile names before year-end.